If you want to know Bionaturis Group latest news, here you are our December Newsletter

Imagen Bionaturis Newsletter

IN THIS ISSUE

    • US Allotropic Tech and Bionaturis Group join forces

 

  • Aquaculture research continues progressing with the Targetfish Project

Let’s get to know…

Maitane Ipiñazar Undurraga, 38 years old, born in Bilbao, Degree in Pharmaceutical Sciences at Navarra University

 

 

Maitane Ipiñazar
 

  • -When you were a child, what did you want to be as an adult?
  • A pilot.
  • -What do you like the most about your job?
  • Having the opportunity of meeting and relating constantly with new people.
  • -What are your future challenges?
  • Continue learning every day both in materia and commercial skills.
  • -Your favourite dish
  • It is very difficult for me to choose only one: I love sea food, fish, pasta…
  • -A place
  • Bilbao. As a good native from Bilbao, it could not be in a different way.
  • -A film
  • ‘Untouchable’.
  • -A historical figure
  • Mother Teresa of Calcutta.
  • -A book
  • Among the ones I have recently read, ‘Tell me who I am’, by Julia Navarro.
  • -A song
  • ‘High’, by Lighthouse Family.
  • -What do you usually do in your free time?
  • Enjoying with my family, spending time with friends and going to the cinema.
  • -You can’t live without…
  • Black locorice.
  • -How do you imagine the world in 20 years?
  • It will be very technological. In relation with health, I hope we will have progressed a lot in oncological and neurodegeneratives therapies.
Maitane has been working as a Business Development Manager at BBD BioPhenix-Biobide (Bionaturis Group) since August, 2015.

US Allotropic Tech and Bionaturis Group join forces

Bionaturis Group and the US-biotech company Allotropic Tech has signed an agreement to work together in the development of biological products for pharmaceutical, petrochemical, nutritional, and cosmetic industries, among others. Allotropic Tech’s personnel are pioneers in the field of expression systems in insects such as FLYLIFE. According to Bionaturis Group’s CEO, Victor Infante, “with this agreement, Bionaturis Group continues adding up strategic alliances and improving its competitiveness. Allotropic’s team is composed of recognized experts at using insects to express difficult to obtain proteins, and therefore, one more value added for our clients and development partners. This agreement will also allow us to broaden our product portfolio” […] Read more

Aquaculture research continues progressing with the Targetfish Project

Bionaturis Group coordinator for Targetfish Project, PhD Ana de las Heras, has recently attended the annual meeting of this European Consortium, devoted to develop and provide the industry with new solutions for the most common diseases in European aquaculture. During the event, held in Athens, Bionaturis has explained the progresses in its developments led to some of the major aquaculture species raised in Europe […] Read more

INVESTOR INFO

Relevant info: Contract with NIH-NIEHS (only in Spanish)  
Relevant info: Result of the revocation and annulment of orders (only in Spanish)  
Relevant info: Incentive for the European project Cervipro (only in Spanish)  
Relevant info: Update of information about the corporate acquisition (only in Spanish)  
Relevant info: Others about financial operations. Decision of the Board of Directors to invalidate the capital increase (Only in Spanish) 


Hi, this newsletter contains information about my website. For any question, please contact to info@bionaturis.com
Imagen Boletín Bionaturis Imagen Twitter Bionaturis Imagen Linked In Bionaturis Imagen Flickr Bionaturis Imagen Youtube Bionaturis Imagen Blog Bionaturis
Este e-mail ha sido enviado por *|EMAIL|*¿Por qué me sale esto? No quiero seguir recibiendo este newsletter Actualizar las preferencias de suscripción

*|LIST:ADDRESSLINE|*

*|REWARDS|*